COLM Study Research Organization

Quick facts

Marketed products

• olmesartan medoxomil / amlodipine or azelnidipine · Cardiovascular
  This combination lowers blood pressure by blocking angiotensin II receptors (olmesartan medoxomil) and calcium channels (amlodipine or azelnidipine) to relax blood vessels.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• COLM Study Research Organization portfolio CI brief
• COLM Study Research Organization pipeline updates RSS